-
Mashup Score: 8European Society for Medical Oncology 2023 Annual Meeting (ESMO 2023) Conference Coverage - 1 year(s) ago
Original content by clinicians, featuring conference coverage, video lectures, and editor commentaries.
Source: www.urotoday.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Join our new Regional Specialty Advisors Panel - 1 year(s) ago
28 November 2022 We’re looking for consultant members to join our new panel where you’ll work closely with the Royal College of Physicians (RCP) to review job descriptions and job roles for consultant, honorary consultant, and specialty doctor posts in England, Northern Ireland, and Wales. As a Regional Specialty Advisor (RSA) you will: review job…
Source: rheumatology.org.ukCategories: Latest Headlines, RheumatologyTweet-
Consultants needed in East Midlands (North), Kent, Surrey and Sussex, Oxford, Severn, and Wessex to join us as Regional Specialty Advisors. You'll work with @RCPhysicians tor review job roles for Consultant, Honorary Consultant, and Specialty Doctors. 👉 https://t.co/VHj5jpAXWC https://t.co/dzb8f9L5IF
-
-
Mashup Score: 1Potential role of cross-education in early-stage rehabilitation after anterior cruciate ligament reconstruction - 1 year(s) ago
Cross-education, which refers to the interlimb transfer of strength or motor skill following unilateral motor training, has demonstrated promise as a rehabilitation strategy for orthopaedic and neurological injuries, despite the limited number of clinical trials conducted. However, its application in anterior cruciate ligament reconstruction (ACLR) rehabilitation has recently been contested, primarily due to the perceived risk of increasing limb asymmetry.1 During ACLR rehabilitation, improved physical function is associated with the ability to restore compromised quadriceps strength and activation.2 Protocols that mitigate and restore quadriceps weakness and strength post-ACLR are a critical component of rehabilitation. Cross-education may attenuate the loss in neuromuscular function during disuse (online supplemental file), serve as an adjunct intervention for increasing quadriceps strength3 and enhance neuroplasticity in pathways known to be attenuated with ACLR (online supplemental
Source: bjsm.bmj.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0
Register for the 25 October Pain, Mind, and Movement SIG webinar, Exploring the Evidence Behind Physical Activity and Pain: Spanning Basic Science to Clinical Application. The webinar will discuss the […]
Source: www.iasp-pain.orgCategories: Latest Headlines, RheumatologyTweet-
Register for the @Pain_Mind_Movem webinar, exploring the evidence behind physical activity and pain, featuring @felipereisifrj, Marie Bement, and @ksluka0101. https://t.co/gMLepMoBTS https://t.co/Q7i6L813KL
-
-
Mashup Score: 0Collaboration aims to make flotufolastat F 18 available in China for prostate cancer imaging - 1 year(s) ago
Urology Times is the leading resource for urologists & allied health professionals offering clinical analysis, policy perspectives, & practical advice.
Source: www.urologytimes.comCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 52Probiotic-guided CAR-T cells for solid tumor targeting - 1 year(s) ago
Engineered probiotics produce synthetic targets to facilitate immunotherapy of solid tumors by CAR T cells.
Source: www.science.orgCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0Healthcare AI News 10/18/23 – HIStalk - 1 year(s) ago
News OpenAI adds voice capabilities to the ChatGPT mobile app, which can carry on a conversation with the user through one of several available natural-sounding voices. Existing voice assistants such as Alexa, Siri, Google Assistant, and Cortana will need to follow quickly or risk becoming instantly obsolete. Rumors suggest that OpenAI will soon launch AI-powered autonomous agents, which can…
Source: histalk2.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 3The case for a Global South centred model in global health - 1 year(s) ago
We need to reframe the approach to decolonising global health by centring the Global South as primary actor and leader, writes Muneera Rasheed Calls to decolonise global health and tackle historic and systemic injustices in the field have intensified in recent years, but sometimes the way the argument is presented can be counterproductive. For those of us in the Global South, the discourse can make us feel that our experiences are invalid. We are often portrayed as helpless and needing to be rescued,1 not by white saviours as in the past, but by well meaning actors in the Global North who are themselves struggling with the legacy of white supremacy, such as racism. This portrayal oversimplifies the power dynamics in the Global South. An essential element of coloniality is that it reproduces itself in colonised countries in the Global South by using incentives—such as granting access to the decision makers in coloniser countries in the Global North. The current discourse overlooks this
Source: www.bmj.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 0
A panel of experts discuss the role of type 2 inflammation in asthma, challenges with long-term use of corticosteroids, and the emerging role of biologics and various mechanisms of actions in the management of asthma.
Source: www.patientcareonline.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 0I.M. Physician Toolkit | ACP Online - 1 year(s) ago
I.M. Physician Toolkit We are Leaders, Experts, Connectors, and Detectors. Use the resources below to help spread the word about internal medicine, and celebrate our profession.
Source: www.acponline.orgCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
We're #IMProud because of members like @haidn, ACP PA Chapter. In 10 days, tag those who make you proud to be an #IMPhysician for #InternalMedicineDay on Oct. 28. Explore our I.M Physician toolkit for resources to spread the word about #InternalMedicine: https://t.co/nNTTRozviN https://t.co/h0RPCjSLdI
-
Looking forward to #ESMO23 presentation by @drlouiseemmett LBA84 - Enzalutamide and 177Lu-PSMA-617 in poor-risk, #mCRPC: a randomized, phase 2 trial: ENZA-p (ANZUP 1901). Visit UroToday for written coverage throughout the conference > https://bit.ly/3FmeO68 @ANZUPtrials @myESMO